HPV and oral carcinogenesis: A bibliographic review;HPV e carcinogênese oral: Revisão bibliográfica

Revista Brasileira de Otorrinolaringologia

Volumn 69, Issue 4, 2003, Pages 553-559

  Oliveira, Márcio C ^a   Soares, Rosilene C ^b   Pinto, Leão P ^b   De Lisboa Lopes Costa, Antônio ^b,c  

^a DEPARTAMENTO DE CIÊNCIAS BIOLÓGICAS   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^c UFRN ^*  (Brazil)

Author keywords

Carcinogenesis; E6 protein; E7 protein; HPV; Oral cancer

Indexed keywords

ALCOHOL; CARCINOGEN; PROTEIN E6; PROTEIN E7; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; TUMOR SUPPRESSOR PROTEIN;

BENIGN TUMOR; CARCINOGENESIS; GENOTYPE; HUMAN; MOUTH CANCER; MOUTH MUCOSA; NONHUMAN; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; REVIEW; SQUAMOUS CELL CARCINOMA; TOBACCO; VIRUS DETECTION; WART VIRUS;

EID: 11144320294     PISSN: 00347299     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0034-72992003000400018     Document Type: Review

References (49)

1. Syrjänen K, Syrjänen S, Lamberg M, Pyrhönen S, Nuutinen J. Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg 1983; 12:418-24.
2. Bouda M, Gorgoulis VG, Kastrinakis NG, Giannoudis A, Tsoli E, Danassi-Afentaki D et al. "High risk" HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Mod Pathol 2000; 13(6):644-53.
3. Elamin F, Steingrimsdottir H, Wanakulasuriya N, Johnson, N, Tavassoli M. Prevalence of human papillomavirus infection in premalignant and malignant lesions of the oral cavity in U. K. subjects: a novel method of detection. Oral Oncol 1998; 34:191-7.
4. Premoli-de-Percoco G, Ramirez JL. High risk human papillomavirus in oral squamous carcinoma: evidence of risk factors in a venezuelan rural population. Preliminary report. J Oral Pathol Med 2001; 30:355-61.
5. Shima K, Kobayashi I, Saito I, Kiyoshima T, Matsuo K, Ozeki S, et al. Incidence of human papillomavirus 16 and 18 infection and p53 mutation in patients with oral squamous cell carcinoma in Japan. British Journal Of Oral and Maxillofacial Surgery 2000; 38:445-50.
6. Summersgill KF, Smith EM, Kirchner HL, Haugen TH, Turek LP. p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 90:334-9.
7. Uobe K, Masuno K, Fang Y-R, Li L-J, Wen Y-M, Ueda Y et al. Detection Of HPV in japanese and chinese oral carcinomas by in situ PCR. Oral Oncology 2001; 37:146-52.
8. Miller CS, Epstein JB, Hall EH, Sirois D. Changing oral care needs in the United States: the continuing need for oral medicine. Oral Surg Oral Med Oral Pathol Oral Radiol Endod Jan 2001; 91(1):34-44.
9. Kojima A, Maeda H, Sugita Y, Tanaka S, Kameyama Y. Human papillomavirus type 38 in oral squamous cell carcinomas. Oral Oncol 2002; 38:591-6.
10. Terai M, Takagi M, Matsukura T, Sata T. Oral wart associated with human papillomavirus type 2. J Oral Pathol Med 1999; 28(3):137-40.
11. Terai M, Burk RD. Complete nucleotide sequence and analysis of a novel human papillomavirus (HPV 84) genome cloned by an overlapping PCR method. Virology 2001; 279:109-15.
12. Scully C, Path MRC, Prime S, Maitland N. Papillomaviruses: their possible role in oral disease. Oral Surg Oral Med Oral Pathol 1985; 60:166-74.
13. Terai M, Takagi M. Human papillomavirus in the oral cavity. Oral Med Pathol 2001; 6:1-12.
14. zur Hausen H. Papillomavirus infections - a major cause of human cancers. Biochimica et biophysica Acta 1996; 1288:F55-F78.
15. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. Journal of the National Cancer Institute 2000; 92(9):690-8.
16. Kitasato H, Delius H, zur Hausen H, Sorger K, Rosl F, de Villiers EM. Sequence rearrangements in the upstream regulatory region of human papillomavirus type 6: are these involved in malignant transition? J Gen Virol May 1994; 75(Pt 5):1157-62.
17. zur Hausen H. Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix. Lancet 1994; 343:955-7.
18. Chang F, Syrjänen S, Kellokoski J, Syrjänen K. Human papillomavirus (HPV) infections and their associations with oral disease. J oral Pathol Med 1991; 20(7):305-17.
19. Kay P, Meehan K, Williamson A. The use of nested polymerase chain reaction and restriction fragment length polymorphism for the detection and typing of mucosal human papillomaviruses in samples containing low copy numbers of viral DNA. J Virol Methods 2002; 105:159-70.
20. Sugerman PB, Shillitoe EJ. The high risk human papillomaviruses and oral cancer: evidence for and against a causal relationship. Oral Diseases 1997; 3:130-47.
21. De Villiers EM. Heterogeneity of the human papillomavirus group. J Virol 1989; 63:4898-903.
22. van Ranst M, Tachezy R, Burk RD. In: Laey C. Human papillomaviruses: a never ending story? London: Leeds Medical Information; 1996. p.1-19.
23. Llewellyn CD, Johnson NW, Warnakulasuriya KAAS. Risk factors for squamous cell carcinoma of the oral cavity in young people - a comprehensive literature review. Oral Oncology 2001; 37:401-18.
24. Lynch DP. Oral viral infections. Clinics in dermatology 2000; 18:619-28.
25. Miller CS, White DK. Human papillomavirus expression in oral mucosa, premalignant conditions, and squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 82:57-68.
26. Praetorius F. HPV-associated diseases of oral mucosa. Clinics in Dermatology 1997; 15:399-413.
27. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst May 2000; 92(9):709-20.
28. Cruz IBF, Snijders PJF, Steenbergen RDM, Meijer CJLM Snow GB, Walboomers JMM et al. Age-dependence of human papillomavirus DNA presence in oral squamous cell carcinomas. Oral Oncol, Eur J Cancer 1996; 32B(1):55-62.
29. Giovanelli L, Campisi G, Lama A, Giambalvo O, Osborn, J, Margiotta V et al. Human Papillomavirus DNA on Oral Mucosal Lesions. The J Infect Dis Mar 2002; 185:833-6.
30. Lee JO, Russo AA, Pavletich NP. Structure of the retinoblastoma tumour-supressor pocket domain bound to a peptide from HPV E7. Nature 1998; 391:859-65.
31. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57-70.
32. Grossman SR, Laimins LA. E6 protein of human papillomavirus type 18 binds zinc. Oncogene Sep 1989; 4(9):1089-93.
33. Rapp L, Chen JJ. The papillomavirus E6 proteins. Biochimica et Biophysica Acta 1998; 1378:1-19.
34. Silverman Jr. S, Sugerman PB. Oral premalignancies and squamous cell carcinoma. Clinics in Dermatology 2000; 18:563-8.
35. Honma M, Momose M, Tanabe H, Sakamoto H, Yu Y, Little JB et al. Requirement of wild-type p53 protein for maintenance of chromosomal integrity. Mol Carcinog 2000; 28:203-14.
36. Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, zur Hausen H. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985; 314:111-4.
37. Lazo PA. The molecular genetics of cervical carcinoma. Britsh Journal of Cancer 1999; 80(12):2008-18.
38. Sastre-Garau X, Favre M, Couturier J, Orth G. Distinct patterns of alteration of myc genes associated with integration of human papillomavirus type 16 or type 45 DNA in two genital tumours. J Gen Virol 2000; 81:1983-93.
39. Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 91:622-35.
40. Yamaguchi T, Shindoh M, Amemiya A, Inoue N, Kawamura M, Sakaoka H et al. Detection of human papillomavirus type 2 related sequence in oral papilloma. Analytical Cellular Pathology 1998; 16:125-30.
41. Woods KV, Shillitoe EJ, Spitz MR, Schantz SP, Adler-Storthz K. Analysis of human papillomavirus DNA in oral squamous cell carcinomas. J Oral Pathol Med 1993; 22:101-8.
42. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 1994; 170:1077-85.
43. Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro CJ Chimera J et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991 Jan; 265(4):472-7.
44. Scully C. Oral squamous cell carcinoma; from an hypothesis about a virus, to concern about possible sexual transmission. Oral Oncology 2002; 38:227-34.
45. Dhariwal SK, Cubie HÁ, Southam JC. Detection of human papillomavirus in oral lesions using commercially developed typing kits. Oral Microbiol Immunol 1995; 10:60-3.
46. De Roda Husman AM, Walboomers JMM, Van Den Brule AJC, Meijer CJLM, Snijders PJF. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent higly conserved sequence improves human papillomavirus detection by PCR. J Gen Virol 1995; 76:1057-62.
47. Scully C, Cox MF, Prime SS, Maitland NJ. Papillomaviruses: the current status in relation to oral disease. Oral Surg Oral Med Oral Pathol 1988; 65(5):526-32.
48. Summersgill KF, Smith EM, Levy BT, Allen JM, Haugen TH, Turek LP. Human papillomavirus in the oral cavities of children and adolescents. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 91:62-9.
49. Villa LL. Human papillomaviruses and cervical cancer. In: Advances in Cancer Res 1997; 71:321-411.